Convalescent Plasma Therapy - Zurich Protocol

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

March 30, 2021

Conditions
COVID-19
Interventions
DRUG

Convalescent plasma

"Convalescent plasma will be delivered as FFP. Three units of 200ml CP/FFP harvested from one donor will be transfused to one recipient, i.e. there will be a match between donor and recipient and each recipient will receive CP/FFP only from one donor.~CP/FFP will be administered intravenously at the infusion rate of 100ml/hour, starting from day 0, with a new transfusion every 24 hours, for a total of 3 transfusions (see scheme)."

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT04869072 - Convalescent Plasma Therapy - Zurich Protocol | Biotech Hunter | Biotech Hunter